Brinker Capital Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Buy
43,713
+1,843
+4% +$32.2K 0.01% 1359
2026
Q1
$803K Buy
41,870
+1,291
+3% +$28.1K 0.01% 1237
2025
Q4
$892K Sell
40,579
-3,403
-8% -$61.4K 0.01% 1294
2025
Q3
$534K Sell
43,982
-629
-1% -$8.51K ﹤0.01% 1525
2025
Q2
$832K Sell
44,611
-2,477
-5% -$49.1K 0.01% 1287
2025
Q1
$902K Buy
47,088
+17,014
+57% +$498K 0.01% 1136
2024
Q4
$1.08M Sell
30,074
-3,589
-11% -$121K 0.01% 1008
2024
Q3
$1.43M Sell
33,663
-3,713
-10% -$157K 0.01% 858
2024
Q2
$1.51M Sell
37,376
-2,854
-7% -$119K 0.02% 778
2024
Q1
$1.42M Buy
40,230
+3,463
+9% +$92.8K 0.02% 818
2023
Q4
$1.04M Buy
+36,767
New +$763K 0.01% 925
2022
Q2
– Sell
-4,973
Closed -$578K – 1422
2022
Q1
$578K Sell
4,973
-99
-2% -$11.6K 0.01% 998
2021
Q4
$763K Buy
+5,072
New +$685K 0.01% 919

Other funds holding TNDM

Brinker Capital Investments's TNDM Position: Q2 2026 in Review

Brinker Capital Investments increased its Tandem Diabetes Care (TNDM) stake by 4.4% in Q2 2026, buying an estimated $32.2K and bringing the position to 43,713 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #1359.

Brinker Capital Investments first reported a position in TNDM in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.51M in Q2 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Brinker Capital Investments held 43,713 shares of Tandem Diabetes Care worth $660K as of Q2 2026.
  • Brinker Capital Investments bought 1,843 Tandem Diabetes Care shares in Q2 2026, an estimated $32.2K.
  • Tandem Diabetes Care made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1359 holding.
  • Brinker Capital Investments first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 13 quarters since.
  • Brinker Capital Investments's Tandem Diabetes Care position peaked at $1.51M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.